Sandeep Gurram

机构：National Institutes of Health, National Cancer Institute · ORCID：0000-0002-6405-9269

发表论文 235 篇 · 总被引 2063 次 · h-index 18

代表论文

• Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer (2025 · New England Journal of Medicine · 被引 29)
• Evaluating Artificial Intelligence–Assisted Prostate Biparametric MRI Interpretation: An International Multireader Study (2025 · American Journal of Roentgenology · 被引 9)
• Top advances of the year: Bladder cancer (2025 · Cancer · 被引 8)
• A multimodal automated deep learning-based model for predicting biochemical recurrence of prostate cancer following prostatectomy from baseline MRI, Presurgical clinical covariates (2025 · Clinical Imaging · 被引 6)
• A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) – design and rationale (2025 · Future Oncology · 被引 6)
• E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors—design and rationale (2025 · Future Oncology · 被引 3)